Chronic lymphocytic leukaemia: open trials in Chile

• NCT05947851

  A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Biocenter (Site 1507), Concepción · IC La Serena Research (Site 1506), La Serena · Centro de Estudios Clínicos SAGA-CECSAGA (Site 1509), Santiago · Bradfordhill (Site 1512), Santiago · FALP-UIDO (Site 1500), Santiago · Clinica Alemana de Santiago (Site 1514), Santiago · Clínica Inmunocel (Site 1511), Santiago

  Registry updated 2026-11-06

• NCT06136559

  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Clínica Alemana de Santiago-Unidad de Investigaciones (Site 2306), Santiago · Bradfordhill-Clinical Area (Site 2310), Santiago · FALP-UIDO (Site 2300), Santiago

  Registry updated 2026-10-13

• NCT05254743

  A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  Trial Treatment · Phase 3 · Loxo Oncology, Inc.

  Inmunocel, Santiago · CeCim Biocinetic, Santiago · Sociedad de Investigaciones Medicas Limitada, Temuco · Centro de Investigaciones Clínicas Viña del Mar (CIC), Viña del Mar

  Registry updated 2026-08-17

All Chronic lymphocytic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error